MAOYAN ENT announced the cancellation of a total of 4,100,800 repurchased common shares on December 27, 2024. These shares were repurchased by the company between August 27 and October 9, 2024. After the cancellation, the total number of shares issued by the company decreased from 1.155 billion shares to 1.151 billion shares.Specifically, the company canceled the following batches of shares: 790,000 shares repurchased on August 27, 806,000 shares on August 28, 500,600 shares on August 29, 537,400 shares on September 2, 830,000 shares on September 9, 304,800 shares on September 19, and 332,000 shares on October 9. The repurchase prices of these shares ranged from HKD 5.9171 to HKD 7.2.This share cancellation reflects MAOYAN ENT's ongoing execution of its share repurchase plan, potentially aimed at optimizing its capital structure or enhancing shareholder value. However, the announcement did not provide further information regarding any repurchase plans or company strategies.

MAOYAN ENT announced the cancellation of a total of 4,100,800 repurchased common shares on December 27, 2024. These shares were repurchased by the company between August 27 and October 9, 2024. After the cancellation, the total number of shares issued by the company decreased from 1.155 billion shares to 1.151 billion shares.Specifically, the company canceled the following batches of shares: 790,000 shares repurchased on August 27, 806,000 shares on August 28, 500,600 shares on August 29, 537,400 shares on September 2, 830,000 shares on September 9, 304,800 shares on September 19, and 332,000 shares on October 9. The repurchase prices of these shares ranged from HKD 5.9171 to HKD 7.2.This share cancellation reflects MAOYAN ENT's ongoing execution of its share repurchase plan, potentially aimed at optimizing its capital structure or enhancing shareholder value. However, the announcement did not provide further information regarding any repurchase plans or company strategies.